REFERENCES
-
1
Harrison C N, Campbell P J, Buck G et al..
for the United Kingdom Medical Research Council Primary Thrombocythaemia 1 Study. Hydroxyurea compared with anagrelide in high-risk essential thrombocythaemia.
N Engl J Med.
2005;
353
33-45
-
2
Koudstaal P J, Koudstaal A.
Neurologic and visual symptoms in essential thrombocythemia: efficacy of low-dose aspirin.
Semin Thromb Hemost.
1997;
23
365-370
-
3
Michiels J J, Berneman Z, Schroyens W, Koudstaal P J, Lindemans J, van Vliet H HDM.
Platelet-mediated thrombotic complications in patients with ET: reversal by aspirin, platelet reduction, and not by coumadin.
Blood Cells Mol Dis.
2006;
36
199-205
-
4
Fruchtman S M, Petitt R M, Gilbert H S, Fiddler G, Lyne A.
Anagrelide: analysis of long-term efficacy, safety and leukemogenic potential in myeloproliferative disorders.
Leuk Res.
2005;
29
481-491
-
5
Michiels J J.
Acquired von Willebrand disease due to increasing platelet count can readily explain the paradox of thrombosis and bleeding in thrombocythemia.
Clin Appl Thromb Hemost.
1999;
5
147-151
-
6
Michiels J J.
Platelet-mediated microvascular inflammation and thrombosis in thrombocythaemia vera: a distinct aspirin-responsive arterial thrombophilia, which transforms into a bleeding diathesis at increasing platelet counts.
Pathol Biol (Paris).
2003;
51
167-175
-
7
Serrano P, Lanas A, Arroyo M T, Ferreira I L.
Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases.
Aliment Pharmacol Ther.
2002;
16
1945-1953
-
8
Michiels J J, Berneman Z, Schroyens W, Finazzi G, Budde U, van Vliet H HDM.
The paradox of platelet activation and impaired function, platelet-von Willebrand factor interactions and the molecular etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Semin Thromb Hemost.
2006;
32
589-604
-
9
Budde U, Dent J A, Berkowitz S D, Ruggeri Z M, Zimmerman T S.
Subunit composition of plasma von Willebrand factor in patients with the myeloproliferative syndrome.
Blood.
1986;
68
1213-1217
-
10
Fabris F, Casonato A, Grazia del Ben M, De Marco L, Girolami A.
Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis.
Br J Haematol.
1986;
63
75-83
Jan J MichielsM.D. Ph.D.
Goodheart Institute, Hemostasis Thrombosis Science Center, Erasmus Tower
Veenmos 13, 3069 AT Rotterdam, The Netherlands
Email: postbus@goodheartcenter.demon.nl
